Back

Supernus Pharmaceuticals Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Sell

SUPN
Supernus Pharmaceuticals

Last Price:

34.66

Seasonality Move:

8.24%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Supernus Pharmaceuticals Stock Forecast

Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 20.8% based on the past 12 years of stock performance.
Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is Supernus Pharmaceuticals Stock Undervalued?
The current Supernus Pharmaceuticals [SUPN] share price is $33.97. The Score for SUPN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
SUPN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Supernus Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 20.8% based on the past 12 years of stock performance.

Supernus Pharmaceuticals Stock Rating

Sell

Supernus Pharmaceuticals (SUPN) is a Sell

Is Supernus Pharmaceuticals overpriced?

Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Supernus Pharmaceuticals Stock Price History

Is SUPN stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

supernus.com

52-Week Data

52-Week High:

35.56

52-Week Low:

23.05

Prediction Charts

Market Cap:

1.87B

Price in USD:

33.97

Volume:

788.78K

Beta:

1.09

Technical Analysis

SMA50:

33.03

SMA100:

31.09

SMA200:

30.49

52-Wk Change:

42.07%

Stock Predictions

Is Supernus Pharmaceuticals stock public?
Yes, Supernus Pharmaceuticals is a publicly traded company.
What is the Supernus Pharmaceuticals stock quote today?
The Supernus Pharmaceuticals stock price is 33.97 USD today.
How to buy Supernus Pharmaceuticals stock online?
You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Oct-15	32.74	33.54	33.65	32.74
Oct-16	33.65	33.98	34.21	33.40
Oct-18	34.09	34.54	34.67	33.71
Oct-21	34.53	33.67	34.53	33.64
Oct-22	33.51	33.71	34.05	33.27
Oct-23	33.54	33.87	33.92	33.35
Oct-24	33.88	33.80	34.30	33.70
Oct-25	33.80	33.93	34.54	33.80
Oct-28	34.32	34.16	34.68	34.00
Oct-29	34.00	34.36	34.38	33.73
Oct-30	34.09	34.94	35.56	33.95
Oct-31	34.69	34.07	35.03	34.01
Nov-1	34.22	33.97	34.55	33.80
Nov-4	33.96	34.76	34.96	33.70

Supernus Pharmaceuticals Earnings

Supernus Pharmaceuticals Earnings Report: Per Share Supernus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Supernus Pharmaceuticals Forecast Revenue Growth

Supernus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.

* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.